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When confronted with potentially lethal bacterial 
sepsis, the brain tells the spleen to shut down the 
production of inflammatory cytokines, according to 
Huston and colleagues on page 1623. This may help 
explain why splenectomy renders people more 
prone to the immunological overreaction of septic 
shock when infected with certain types of bacteria.
When the brain detects inflammation or injury, it 
sends signals along the vagus nerve—the meandering 
nerve that regulates vital functions such as heart 
rate and digestion. This 
signal triggers the release 
of the neurotransmitter 
acetylcholine (Ach) from 
peripheral nerve endings. 
Ach then binds to its 
receptor on immune 
cells  and inhibits the 
production of inflamma-
tory cytokines, in part 
by inhibiting the activa-
tion of the transcription 
factor NF-κB. This cir-
cuit is known as the 
cholinergic antiinflammatory pathway.
Electrical stimulation of the vagus nerve suppresses 
cytokine production in several rodent models of 
inflammation. During bacterial sepsis, according to 
Huston et al., the vagus nerve’s stop signal must be 
delivered to the spleen, as removing the spleen or 
severing the branch of the vagus nerve that innervates 
the spleen abolished the antiinflammatory effect.
The spleen produced the bulk of the shock-
inducing cytokine TNF in this model, possibly 
explaining why this organ had to receive the vagus 
nerve signal. But senior author Kevin Tracey suspects 
that Ach release always occurs in the spleen, even 
when the inflammation is happening elsewhere—
a hunch they are now testing in an arthritis model.
Tracey thinks that vagus nerve signals might 
educate white blood cells in the spleen, through 
which circulating cells transit every 2 to 3 min. 
How immune cells might translate this splenic 
schooling to inflammation control at distant sites 
remains to be determined. In the meantime, im-
planted pacemaker-like devices that zap the vagus 
nerve—used to treat seizure disorders—might also 
be useful for treating inflammatory diseases. 
Finding NEMO mutations
A wide variety of inflammatory stimuli trigger the activation of IκB kinase 
(IKK), the enzyme complex that activates the NF-κB transcription factors. But 
all NF-κB–inducing signals are not the same, according to Filipe-Santos and 
colleagues (page 1745), who identify mutations in the regulatory subunit of 
IKK that selectively disarm just one of these pathways.
Most NF-κB–inducing stimuli, including byproducts of microbial infection and 
inflammatory cytokines, trigger the phosphorylation of the α and β subunits of IKK. 
Heterodimers of IKKα and β then bind to IKKγ (or NEMO)—the regulatory subunit 
of the complex. Thus assembled, this protein complex phosphorylates the NF-κB 
inhibitor proteins (IκBs), tagging it for proteasomal degradation and freeing NF-κB 
for translocation into the nucleus.
Here, Filipe-Santos et al. identify two point mutations in NEMO in patients 
with an X-linked susceptibility to mycobacterial infection. These mutations 
blocked the NF-κB–driven production of interleukin (IL)-12 by monocytes and 
dendritic cells (DCs). But this block occurred only in response to T cell–based 
signals, triggered by the interaction between CD40 ligand (on activated T cells) 
and its partner CD40 (on monocytes and DCs). IL-12 production in response to 
other IKK-inducing stimuli (including bacterial LPS and live mycobacteria) was unaffected.
It is unclear why these NEMO mutations, both in the protein’s leucine zipper (LZ) domain, preferentially affect 
CD40-induced signals. One possibility is that NEMO interacts with distinct IKK-activating kinases depending on 
the upstream signal, and the LZ domain is required for NEMO to latch on to a specific CD40-triggered kinase.
From the disease standpoint, it makes sense that IL-12–blocking NEMO mutations predispose people 
to mycobacterial infection, as IL-12 is known to be essential for defending against mycobacteria. 
Monocytes infected with mycobacteria themselves produce IL-12, but these data suggest that infection-
induced IL-12 is not enough to control the growth of the bug. Perhaps the amount of IL-12 is simply too 
low unless T cells get in on the act. 
Vagus nerve delivers antiinflammatory signals to 
the spleen.
CD40-induced nuclear accumulation of NF-𝗋B 
(green) is blocked by NEMO mutations.
Splenic schooling dampens inflammation
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